NCT00472199 - Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS) | Biotech Hunter

Enrollment

331

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

July 31, 2008

Conditions

Restless Legs Syndrome

Interventions

DRUG

Pramipexole

DRUG

Placebo

Trial Locations (42)

Unknown

248.629.4302 Boehringer Ingelheim Investigational Site, Innsbruck

248.629.4304 Boehringer Ingelheim Investigational Site, Linz

248.629.3201 Boehringer Ingelheim Investigational Site, Edegem

248.629.35801 Boehringer Ingelheim Investigational Site, Espoo

248.629.35805 Boehringer Ingelheim Investigational Site, Helsinki

248.629.35804 Boehringer Ingelheim Investigational Site, Joensuu

248.629.35802 Boehringer Ingelheim Investigational Site, Oulu

248.629.35806 Boehringer Ingelheim Investigational Site, Tampere

248.629.4902 Boehringer Ingelheim Investigational Site, Berlin

248.629.4908 Boehringer Ingelheim Investigational Site, Bochum

248.629.4901 Boehringer Ingelheim Investigational Site, Ellwangen

248.629.4904 Boehringer Ingelheim Investigational Site, Hellersdorf

248.629.4906 Boehringer Ingelheim Investigational Site, Herborn

248.629.4905 Boehringer Ingelheim Investigational Site, Leipzig

248.629.4909 Boehringer Ingelheim Investigational Site, Schwerin

248.629.4903 Boehringer Ingelheim Investigational Site, Steglitz

248.629.4907 Boehringer Ingelheim Investigational Site, Würzburg

248.629.35301 Boehringer Ingelheim Investigational Site, Carrigtohill

248.629.35302 Boehringer Ingelheim Investigational Site, Co. Kildare

248.629.35303 Boehringer Ingelheim Investigational Site, Co. Tipperary

248.629.31001 Boehringer Ingelheim Investigational Site, Bennebroek

248.629.31005 Boehringer Ingelheim Investigational Site, Hoogwoud

248.629.31006 Boehringer Ingelheim Investigational Site, Musselkanaal

248.629.31002 Boehringer Ingelheim Investigational Site, Oude Pekela

248.629.31003 Boehringer Ingelheim Investigational Site, Oude Pekela

248.629.31004 Boehringer Ingelheim Investigational Site, Rijswijk

248.629.4204 Boehringer Ingelheim Investigational Site, Bratislava

248.629.4205 Boehringer Ingelheim Investigational Site, Bratislava

248.629.4202 Boehringer Ingelheim Investigational Site, Brezno

248.629.4201 Boehringer Ingelheim Investigational Site, Košice

248.629.4203 Boehringer Ingelheim Investigational Site, Martin

248.629.3402 Boehringer Ingelheim Investigational Site, Barcelona

248.629.3405 Boehringer Ingelheim Investigational Site, Granada

248.629.3401 Boehringer Ingelheim Investigational Site, Madrid

248.629.3403 Boehringer Ingelheim Investigational Site, San Sebastián

248.629.3406 Hospital Arnau de Vilanova, Valencia

248.629.44003 Boehringer Ingelheim Investigational Site, Chorley

248.629.44006 Boehringer Ingelheim Investigational Site, Edgbaston, Birmingham

248.629.44004 Boehringer Ingelheim Investigational Site, Glasgow

248.629.44001 Boehringer Ingelheim Investigational Site, Manchester

248.629.44002 Boehringer Ingelheim Investigational Site, Reading

248.629.44005 Boehringer Ingelheim Investigational Site, Waterloo, Liverpool